Sample report for a fictional brand. Run a free scan to see yours.Run a free scan
Compliance audit report

northpeak-wellness.example

9 pages scanned · Nov 18, 2026 · 14:02 · Northpeak Wellness (fictional)
High risk
Veylant provides automated risk indicators, not legal advice. Findings may be incomplete; review them with your counsel.
68/ 100 risk score
LowModerateHighSevere
Product UI · sample data

Findings

7 findings
FDA-001Critical

Branded-drug equivalence claim

/semaglutide
Same active ingredient as Ozempic®FDA-001, without the brand-name price.
Reference: FD&C Act misbranding provisions; FDA statements on compounded GLP-1 products
RemediationRemove the equivalence claim. State that compounded semaglutide is not FDA-approved and is not the same as branded products.
PIX-001High

Meta Pixel fires on an intake page

/intake/step-2
GET connect.facebook.netPIX-001/signals/config/… · fired on /intake/step-2
Reference: FTC Health Breach Notification Rule; HHS OCR guidance on online tracking technologies
RemediationRemove the Meta Pixel from intake and checkout routes. If conversion tracking is required, send consented, server-side events that contain no health information.
PIX-003High

Health keyword in TikTok pixel payload

/semaglutide
analytics.tiktok.com/api/v2/pixel?event=ViewContent&treatment=semaglutidePIX-003&…
Reference: FTC Health Breach Notification Rule; FTC enforcement on health data shared with advertisers
RemediationStrip treatment, condition and medication names from all tracker parameters, URLs and event names before they leave the browser.
ROSCA-001High

Auto-renewal terms placed away from the purchase button

/checkout
Your plan renews automatically every 30 days until cancelled.ROSCA-001 (shown below the fold, 640px under “Start treatment”)
Reference: Restore Online Shoppers’ Confidence Act (ROSCA); FTC negative-option guidance
RemediationPlace the renewal amount, frequency and how to cancel directly above the “Start treatment” button, and capture express consent with an unchecked checkbox.
LGS-001Medium

Dispensing pharmacy not identified

/, /semaglutide, /checkout, /legal/terms
No pharmacy name, location or license foundLGS-001 on any crawled page.
Reference: LegitScript Healthcare Merchant Certification standards (pharmacy transparency)
RemediationName the dispensing pharmacy or pharmacies, their state, and license information on treatment pages and in your terms.
FDA-004Medium

Unqualified weight-loss outcome claim

/
“Lose 20% of your body weightFDA-004. Start today.”
Reference: FTC Health Products Compliance Guidance (substantiation and typical results)
RemediationQualify the outcome: cite the source, state that results vary, and describe typical results alongside diet and exercise.
LGS-004Low

State availability not linked from treatment pages

/semaglutide
No link to state availabilityLGS-004 found near the eligibility quiz.
Reference: LegitScript-style disclosure checks; state telehealth licensure transparency
RemediationLink a page that lists the states where clinicians can treat patients, close to the quiz and checkout entry points.

Ready to see your own report?

Run a free scan of your homepage, treatment, intake, checkout and legal pages.

FreeNo cardResults in about two minutes

Copied